Hot Features
Premium
Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Período:
Tipo de Línea:
| Volume | 990 |
|
|||||
| Noticias | - |
| Nombre de la Acción | Símbolo de la Acción | Bolsa de Valores | Tipo de Valor |
|---|---|---|---|
| Astrazeneca Plc | 0A4J | London | Acción Ordinaria |
| Variación del Día (ptos.) | Variación del Día (%) | Último Precio | Hora
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | - |
| Precio de Apertura | Precio Mínimo | Precio Máximo | Precio de cierre | Precio Anterior |
|---|---|---|---|---|
| Operaciones | Volume Operado de la Acción | Volumen promedio |
|---|---|---|
| 49 | 990 | - |
| Último Operado | Tipo de Operación | Cantidad Operada | Precio Operado | Divisa |
|---|---|---|---|---|
| 12:55:51 | O | 2 | US$ 75.985 | USD |
Información Financiera Astrazeneca Plc 0A4J
| Capitalización de Mercado [m] | Acciones en circulación | Float | Ingresos | Ganancia/Pérdida | Utilidad por Acción (UPA) | Ratio Precio/Utilidad |
|---|---|---|---|---|---|---|
| US$ 0.00 | - | - | - | - |
| Interés de corto | Dividendos Por Acción | Rendimiento del Dividendo | Fecha esperada de dividendos | Transacciones ejecutivas | % de acciones controladas por todos los ejecutivos y 5% propietarios: |
|---|---|---|---|---|---|
| - | - | - | - |
Noticias sobre Astrazeneca Plc 0A4J
| Fecha | Hora | Fuente | Noticias Artículo |
|---|---|---|---|
| 02/1/2024 | 09:00 | UK Regulatory | AstraZeneca PLC Total Voting Rights |
| 27/12/2023 | 01:00 | UK Regulatory | AstraZeneca PLC AstraZeneca acquires Gracell |
| 22/12/2023 | 01:00 | UK Regulatory | AstraZeneca PLC Wainua (eplontersen) granted first US FDA.. |
| 14/12/2023 | 09:00 | UK Regulatory | AstraZeneca PLC Director/PDMR Shareholding |
| 12/12/2023 | 01:05 | UK Regulatory | AstraZeneca PLC AstraZeneca to acquire Icosavax |
| 01/12/2023 | 09:05 | UK Regulatory | AstraZeneca PLC Block listing Interim Review |
| 01/12/2023 | 09:00 | UK Regulatory | AstraZeneca PLC Total Voting Rights |
| 01/12/2023 | 01:00 | UK Regulatory | AstraZeneca PLC Discontinuation of two CRYSTALIZE evidence.. |
| 23/11/2023 | 09:00 | UK Regulatory | AstraZeneca PLC Director/PDMR Shareholding |
| 17/11/2023 | 01:00 | UK Regulatory | AstraZeneca PLC Truqap approved in US for HR+ breast cancer |
| 14/11/2023 | 01:05 | UK Regulatory | AstraZeneca PLC Update on PACIFIC-2 Phase III trial for.. |
| 09/11/2023 | 09:00 | UK Regulatory | AstraZeneca PLC Director Declaration |
Histórico de Datos 0A4J
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00% |
| 1 Month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00% |
| 3 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00% |
| 6 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00% |
| 1 Year | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00% |
| 3 Years | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00% |
| 5 Years | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00% |
